PubMed:32736597 / 4047-4328 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T92","span":{"begin":186,"end":194},"obj":"SP_7"},{"id":"T93","span":{"begin":230,"end":248},"obj":"CHEBI:5801"},{"id":"T94","span":{"begin":230,"end":248},"obj":"DG_20"},{"id":"T95","span":{"begin":230,"end":248},"obj":"CHEBI:5801"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"During treatment, each subject will be contacted every other day for the first week and weekly thereafter (Group 2) or weekly (Group 1) by a study physician to assess early onset of any COVID-19 symptom or any adverse reaction to hydroxychloroquine and to check subject compliance."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T34","span":{"begin":186,"end":194},"obj":"Disease"}],"attributes":[{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"During treatment, each subject will be contacted every other day for the first week and weekly thereafter (Group 2) or weekly (Group 1) by a study physician to assess early onset of any COVID-19 symptom or any adverse reaction to hydroxychloroquine and to check subject compliance."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T51","span":{"begin":139,"end":140},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"During treatment, each subject will be contacted every other day for the first week and weekly thereafter (Group 2) or weekly (Group 1) by a study physician to assess early onset of any COVID-19 symptom or any adverse reaction to hydroxychloroquine and to check subject compliance."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T31","span":{"begin":230,"end":248},"obj":"Chemical"}],"attributes":[{"id":"A31","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"}],"text":"During treatment, each subject will be contacted every other day for the first week and weekly thereafter (Group 2) or weekly (Group 1) by a study physician to assess early onset of any COVID-19 symptom or any adverse reaction to hydroxychloroquine and to check subject compliance."}

{"project":"LitCovid-sentences","denotations":[{"id":"T29","span":{"begin":0,"end":281},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"During treatment, each subject will be contacted every other day for the first week and weekly thereafter (Group 2) or weekly (Group 1) by a study physician to assess early onset of any COVID-19 symptom or any adverse reaction to hydroxychloroquine and to check subject compliance."}

{"project":"LitCovid-PubTator","denotations":[{"id":"132","span":{"begin":186,"end":194},"obj":"Disease"},{"id":"133","span":{"begin":230,"end":248},"obj":"Chemical"}],"attributes":[{"id":"A132","pred":"tao:has_database_id","subj":"132","obj":"MESH:C000657245"},{"id":"A133","pred":"tao:has_database_id","subj":"133","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"During treatment, each subject will be contacted every other day for the first week and weekly thereafter (Group 2) or weekly (Group 1) by a study physician to assess early onset of any COVID-19 symptom or any adverse reaction to hydroxychloroquine and to check subject compliance."}